Your Health and Fitness Partner: Androxal & FitHub

We are also excited to expand our scope by including valuable information on Androxal, a potent medication beneficial in various medical conditions. This remarkable drug, derived from the testosterone molecule, has made its mark significantly in the field of endocrinology. Patients and medical professionals can rely on our comprehensive, unbiased, and scientifically grounded content on Androxal for gaining a robust understanding of its uses, side effects, and the latest studies related to it. We understand the necessity of accurate information when it comes to medication. Our newly launched section dedicated to Androxal aims at not only educating the readers about its nuances but also at contributing beneficially to their wellbeing. Stay tuned for insightful articles unraveling the potential of Androxal in medical science.

Sitemap | Policies | Feedback    
 About the Journal
Editorial Board
Journal Subscription
Instructions for Authors
E-mail Alerts
Forthcoming Events
Advertise with Us
Contact Us
 
Article Options
FULL TEXT
ABSTRACT
PDF
Printer Friendly Version
Search Pubmed for
Search Google Scholar for
Article Statistics
Bookmark and Share
 
Profile of patients with incidentally detected nonalcoholic fatty liver disease (IDNAFLD) in coastal eastern India
 

prednisolone

prednisolon 25 mg mikemaloney.net
Shivaram Prasad Singh1, Sanjib Kumar Kar1, Manas Kumar Panigrahi1, Bijay Misra1, Kaumudee Pattnaik2, Pallavi Bhuyan2, Chudamani Meher3, Omprakash Agrawal3, Niranjan Rout4,Manorama Swain5
Department of Gastroenterology1,
Pathology2 and Biochemistry5,
S.C.B. Medical College
Department of Radiology3, Beam
Diagnostics Centre, Bajrakabati Road
Department of Oncopathology4,
A.H.Regional Cancer Center,
Cuttack 753007, India.


Corresponding Author
: Dr Shivaram Prasad Singh
Email:scb_gastro_dept@hotmail.com


Abstract

Background and Aim: Non-alcoholic fatty liver disease (NAFLD) has emerged as the commonest hepatic problem in both developed and developing countries. This study was conducted to delineate the clinical profile of incidentally detected NAFLD patients.

Methods: A retrospective analysis of clinical, biochemical and histological parameters was performed for 632 patients in whom fatty liver was diagnosed by ultrasonography during 2006-2010. Every patient’s clinical presentation, history, liver function tests, blood sugar, lipid profile, ultrasonogram, histology and other relevant investigations were analyzed. Patients referred for transaminitis or overt chronic liver disease were excluded.

Results: Out of 632 consecutive NAFLD patients, 484 (76.6%) were males and 148 (23.4%) were females. Mean age of our patients was 42.44 ± 10.18 years. Their mean body mass index (BMI) was 26.14 ± 3.38 kg/m2. Obesity (BMI>25), diabetes mellitus, hypertension, hyperlipidemia, metabolic syndrome and insulin resistance were present in 61.7%, 15.2%, 19.8%, 62.0%, 40.0%, and 54.4% patients, respectively. SGOT and SGPT were elevated in 38.29% and 55.1% patients, respectively. The common primary diseases for which these patients sought consultation were non-ulcer dyspepsia (NUD) (54.5%) and irritable bowel syndrome (IBS) (29.4%). Of the 64 patients who underwent liver biopsy, one-fourth had definite NASH while one-third patients had fibrosis.

Conclusion: In India, incidentally detected NAFLD (IDNAFLD) patients are predominantly middle aged males, most of whom are not lean. Most of these patients seek consultation for functional bowel disease.